Rett syndrome is a rare genetic neurological condition that typically emerges in infancy and primarily affects girls, though ...

EpiVax, Inc., a leader in preclinical immunogenicity assessment for biologic therapeutics and vaccines, is pleased to announce the appointment ...

Aeva® , a leader in next-generation sensing and perception systems, today announced that Swiss Urban autonomy software provider Loxo has selected its long-range 4D LiDAR technology for integration ...

Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), today announced that it plans to restructure the organization to optimize resource allocation and improve operational efficiency.

They weren’t snakes, of course, but nematodes, also known as roundworms—and, it turns out, they’re the most common ...

Wilson's new company, Philadelphia-based Gemma Biotherapeutics, plans to start testing gene therapies in Brazil this year.

A team of scientists from the San Raffaele-Telethon Institute for Gene Therapy (SR-Tiget) in Milan, Italy, has identified a ...

Readers respond to an article about gene editing and object to cuts in research funding. Also: The Covid vaccine; Senator ...

The personalized CRISPR treatment could be the future of gene therapy, but hurdles remain before everyone has access.

Qure divested for $25M, advanced AMT-130 with FDA approvals, and building infrastructure. A strong balance sheet backs ...

Researchers at the National University of Singapore (NUS) have developed a scalable, non-viral technology that efficiently ...

Rui Tostoes, Chief Technology Officer at ImmuneBridge, shares how his team is redefining preclinical development and ...